Junpyo Gong

Junpyo Gong

Auto-generated profile, based on publicly available information

Junpyo Gong

College of Pharmacy, Natural Products Research Institute, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2025 in Toxicology
Verified
Journal Article
Closed access
JGJunpyo Gong
Junpyo Gong
IPIn Guk Park
In Guk Park
SHSeokyoung Hwang
Seokyoung Hwang
JCJayhyun Cho
Jayhyun Cho
MLMin Ju Lee
Min Ju Lee
MNMinsoo Noh
Minsoo Noh

16 November 2023 in Scientific Data
Verified
Journal Article
Open access
PDF file
JGJunpyo Gong
Junpyo Gong
JYJeong Sang Yi
Jeong Sang Yi
HCHang Su Cho
Hang Su Cho
CSChang Hun Shin
Chang Hun Shin
HWHyung-Jin Won
Hyung-Jin Won
Yeo Joon YoonYeo Joon Yoon
Yeo Joon Yoon
Streptomyces clavuligerus NRRL 3585 is a native producer of clavulanic acid (CA), a clinically used β-lactamase inhibitor, and is widely used as an industrial strain for the production of antibiotics. Selective random mutagenesis has successfully generated the improved CA-producing S. clavuligerus mutant strains as well as the strain with the loss of CA biosynthesis. To understand the molecular mechanisms associated with the improved CA-production potential, genome-scale RNA-sequencing-based transcriptional data were obtained for the wild-type S. clavuligerus strain and its three mutant strains. Total RNA samples for each strain were collected across four different growth stages, and all 32 sequencing data points exhibited an average Phred score of 36. The high-quality genome-scale transcriptional profile of S. clavuligerus strains with varied CA biosynthetic potential provides valuable insights and new opportunities for discovering efficient metabolic engineering strategies for the development of improved industrial strains.